drugset / Trial / NCT01916304
Study of Dose Adjustment From Levothyroxine to a New Levothyroxine Sodium Test Formulation
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to investigate the effect of switching participants taking levothyroxine to a new sodium formulation.
Timeline
- Start
- 2013-07
- Primary completion
- 2014-06
- Completion
- 2014-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Levothyroxine | Other / unclassified | 25 ug | Oral |
| Subject | Levothyroxine | Other / unclassified | 225 ug | Oral |